Position
Squarepoint Ops LLC in CytomX Therapeutics, Inc.
Back to the book · All holders of CTMX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $22K$4.26 → $4.70
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 49.9K | $212.6K | — | — | — | 0.0% |
| Q1 2026 | 241.2K | $1.13M | $4.70 | $22K | $899.2K | 0.0% |